Augma Biomaterials is a dynamic and innovative company focused on developing bone substitutes for bone augmentation in maxillofacial surgery. Their core activities include the development of novel augmentative products based on extensive personal experience to address challenges faced by clinicians in the dental field. Additionally, they provide services and broad support to clinicians to ensure better, faster, and achievable results. The company's mission is dedicated to the development, production, and marketing of natural mineral bone substitutes for the dental market, focusing on innovative materials for bone augmentation. Augma Biomaterials aims to find simple solutions for diverse requirements in dental implantation and complex surgical procedures.